Meitav Investment House’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,305,674
Closed -$44.9M 344
2023
Q4
$44.9M Buy
4,305,674
+1,950,500
+83% +$20.3M 0.66% 45
2023
Q3
$24.3M Sell
2,355,174
-1,420,000
-38% -$14.6M 0.39% 71
2023
Q2
$28.7M Buy
3,775,174
+889,432
+31% +$6.75M 0.46% 65
2023
Q1
$25.5M Buy
2,885,742
+220,384
+8% +$1.94M 0.44% 70
2022
Q4
$24.9M Sell
2,665,358
-12,000
-0.4% -$112K 0.43% 68
2022
Q3
$20.9M Buy
2,677,358
+1,474,889
+123% +$11.5M 0.37% 70
2022
Q2
$9.01M Buy
1,202,469
+3,000
+0.3% +$22.5K 0.15% 114
2022
Q1
$11.2M Buy
1,199,469
+683,969
+133% +$6.4M 0.17% 110
2021
Q4
$4.13M Sell
515,500
-654,044
-56% -$5.24M 0.07% 169
2021
Q3
$11.4M Buy
1,169,544
+409,128
+54% +$3.98M 0.19% 116
2021
Q2
$7.53M Buy
760,416
+87,839
+13% +$870K 0.19% 102
2021
Q1
$7.76K Buy
672,577
+24,017
+4% +$277 0.22% 98
2020
Q4
$6.26M Buy
648,560
+7,700
+1% +$74.3K 0.25% 81
2020
Q3
$5.77M Buy
640,860
+147,167
+30% +$1.32M 0.29% 76
2020
Q2
$6.08M Buy
493,693
+175,469
+55% +$2.16M 0.36% 67
2020
Q1
$2.84M Buy
318,224
+307,924
+2,990% +$2.75M 0.21% 76
2019
Q4
$100K Sell
10,300
-1,000
-9% -$9.71K 0.01% 418
2019
Q3
$79K Sell
11,300
-334,394
-97% -$2.34M 0.01% 436
2019
Q2
$3.19M Sell
345,694
-5,029
-1% -$46.4K 0.21% 64
2019
Q1
$5.5M Sell
350,723
-84,413
-19% -$1.32M 0.31% 55
2018
Q4
$6.71M Buy
435,136
+347,866
+399% +$5.37M 0.42% 60
2018
Q3
$1.87M Buy
87,270
+47,307
+118% +$1.02M 0.09% 145
2018
Q2
$956K Sell
39,963
-92,841
-70% -$2.22M 0.04% 212
2018
Q1
$2.27M Sell
132,804
-131,907
-50% -$2.25M 0.12% 88
2017
Q4
$5.02M Buy
+264,711
New +$5.02M 0.29% 69